Related references
Note: Only part of the references are listed.Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants
Aline H. Saad et al.
PHARMACOTHERAPY (2006)
The complexity of intestinal absorption and exsorption of digoxin in rats
Hsuan-Ming Yao et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Epigallocatechin-3-gallate (EGCG): Chemical and biomedical perspectives
Dale G. Nagle et al.
PHYTOCHEMISTRY (2006)
A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts
A Heyerick et al.
MATURITAS (2006)
Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity
NP Seeram et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2006)
Plant polyphenols and multidrug resistance: Effects of dietary flavonoids on drug transporters in Caco-2 and MDCKII-MDR1 cell transport models
R Rodriguez-Proteau et al.
XENOBIOTICA (2006)
Computational models for identifying potential P-glycoprotein substrates and inhibitors
Patrizia Crivori et al.
MOLECULAR PHARMACEUTICS (2006)
Current industrial practices of assessing permeability and P-glycoprotein interaction
PV Balimane et al.
AAPS JOURNAL (2006)
Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: Influence of cell line and modulator concentration on P-GP activity
ME Taub et al.
DRUG METABOLISM AND DISPOSITION (2005)
Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists
B Ebert et al.
CARCINOGENESIS (2005)
In vivo effects of cyclosporin A and ketoconazole on the pharmacokinetics of representative substrates for P-glycoprotein and cytochrome P450 (CYP) 3A in rats
M Kageyama et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney
T Mikkaichi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey
KW Ward et al.
DRUG METABOLISM AND DISPOSITION (2004)
Development and characterization of an open tubular column containing immobilized P-glycoprotein for rapid on-line screening for P-glycoprotein substrates
R Moaddel et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2004)
Variation of peptide transporter (PepT1 expression in Caco-2 cells as a function and HPT1) of cell origin
I Behrens et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Exploring the quantitative relationship between the level of MDR1 transcript, protein and function using digoxin as a marker of MDR1-dependent drug efflux activity
J Taipalensuu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Herbal modulation of P-glycoprotein
SF Zhou et al.
DRUG METABOLISM REVIEWS (2004)
Modulation of P-glycoprotein-mediated multidrug resistance by flavonoid derivatives and analogues
M Hadjeri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Sulfate conjugating and transport functions of MDCK distal tubular cells
KH Ng et al.
KIDNEY INTERNATIONAL (2003)
Messenger RNA expression of transporter and ion channel genes in undifferentiated and differentiated Caco-2 cells compared to human intestines
P Anderle et al.
PHARMACEUTICAL RESEARCH (2003)
Cellular uptake and efflux of the tea flavonoid (-)-epicatechin-3-gallate in the human intestinal cell line Caco-2
JB Vaidyanathan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man
LB Goh et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Are MDCK cells transfected with the human MRP2 gene a good model of the human intestinal mucosa?
FX Tang et al.
PHARMACEUTICAL RESEARCH (2002)
Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols
J Jodoin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2002)
Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine
GK Dresser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Interaction of common azole antifungals with P glycoprotein
EJ Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Role of transport proteins in drug absorption, distribution and excretion
A Ayrton et al.
XENOBIOTICA (2001)
Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction
A Eneroth et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Inhibitory effect of the reversal agents V-104, GF120918 and pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport
R Evers et al.
BRITISH JOURNAL OF CANCER (2000)
Prenylated xanthones as potential P-glycoprotein modulators
DN Tchamo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro
CL Miranda et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2000)
Share Paper
